http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-541373-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5053f82a7cd17c60822674b657cfb89e
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2004-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44b88f795e587053ca53040cb30f49f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e13f5514fa42ebfb804c3bcc5c58a4d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97f8d9b71b4e8ff014827e798f281e3d
publicationDate 2008-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-541373-A
titleOfInvention Pharmaceutical process for preparing sulfinyl compounds by oxidation of sulfide compounds that are useful as proton pump inhibitors
abstract The present disclosure relates to a process for preparing a sulfinyl compound of formula (I), or a pharmaceutically acceptable salt, hydrate or solvate thereof. The process comprises oxidation of a sulfide compound of formula (II) wherein in both formulae (I) and (II) R1 and R3 are selected from the group consisting of hydrogen, methyl or C1-4 alkoxy, R2 is selected from the group consisting of substituted or unsubstituted C1-4 alkoxy and R4 is selected from the group consisting of hydrogen or substituted or unsubstituted C1-4alkoxy; wherein an oxidising agent comprising an aqueous alkali or alkali earth metal hypohalite solution, having a concentration in the range of 2 to 5%, is added to a suspension or solution of a sulfide compound of formula (II) to form a reaction mixture, wherein a solution of an alkali or alkali earth metal hydroxide is present in the reaction mixture at least during the oxidation step, whereby the pH of the reaction mixture at least during said oxidation step is in the range of from 9 to 12, and optionally converting a sulfinyl compound of formula (I) to a pharmaceutically acceptable salt, hydrate or solvate thereof.
priorityDate 2003-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665760
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415057377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192113
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411303093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506429
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457814463
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14720269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558762
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504775
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393281
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448270076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69761375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450059958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23673712
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457308642
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13982952
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID81531
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154053230
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72171
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23667635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61739
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22172658
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6342
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433725676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410634091
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70139389
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420602145
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452802464
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505875
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152732532
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526493
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92125
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431671887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415749382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9949996

Total number of triples: 80.